Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALPROSTADIL vs TAFLUPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALPROSTADIL vs TAFLUPROST: Safety Overview

Metric ALPROSTADIL TAFLUPROST
Total FAERS Reports 2,800 1,677
Deaths Reported 60 282
Death Rate 2.1% 16.8%
Hospitalizations 210 75
Average Patient Age 62.5 yrs 76.0 yrs
% Female Patients 4.9% 73.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 5, 2024
Manufacturer ENDO USA, Inc. Micro Labs Limited
Route INTRACAVERNOUS OPHTHALMIC
Marketing Status Prescription Prescription